These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
492 related articles for article (PubMed ID: 34768601)
1. The Emerging Role of Gut Microbiota in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Current Evidence and Potential Therapeutic Applications. Varesi A; Deumer US; Ananth S; Ricevuti G J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768601 [TBL] [Abstract][Full Text] [Related]
2. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Nagy-Szakal D; Williams BL; Mishra N; Che X; Lee B; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Ramanan D; Jain K; Eddy ML; Hornig M; Lipkin WI Microbiome; 2017 Apr; 5(1):44. PubMed ID: 28441964 [TBL] [Abstract][Full Text] [Related]
3. Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome. Mandarano AH; Giloteaux L; Keller BA; Levine SM; Hanson MR PeerJ; 2018; 6():e4282. PubMed ID: 29375937 [TBL] [Abstract][Full Text] [Related]
4. The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS). König RS; Albrich WC; Kahlert CR; Bahr LS; Löber U; Vernazza P; Scheibenbogen C; Forslund SK Front Immunol; 2021; 12():628741. PubMed ID: 35046929 [TBL] [Abstract][Full Text] [Related]
5. Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Shukla SK; Cook D; Meyer J; Vernon SD; Le T; Clevidence D; Robertson CE; Schrodi SJ; Yale S; Frank DN PLoS One; 2015; 10(12):e0145453. PubMed ID: 26683192 [TBL] [Abstract][Full Text] [Related]
6. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Giloteaux L; Goodrich JK; Walters WA; Levine SM; Ley RE; Hanson MR Microbiome; 2016 Jun; 4(1):30. PubMed ID: 27338587 [TBL] [Abstract][Full Text] [Related]
7. Evidence for Peroxisomal Dysfunction and Dysregulation of the CDP-Choline Pathway in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Che X; Brydges CR; Yu Y; Price A; Joshi S; Roy A; Lee B; Barupal DK; Cheng A; Palmer DM; Levine S; Peterson DL; Vernon SD; Bateman L; Hornig M; Montoya JG; Komaroff AL; Fiehn O; Lipkin WI medRxiv; 2022 Jan; ():. PubMed ID: 35043127 [TBL] [Abstract][Full Text] [Related]
8. A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). Corbitt M; Campagnolo N; Staines D; Marshall-Gradisnik S Probiotics Antimicrob Proteins; 2018 Sep; 10(3):466-477. PubMed ID: 29464501 [TBL] [Abstract][Full Text] [Related]
9. Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome. Maes M; Leunis JC; Geffard M; Berk M Neuro Endocrinol Lett; 2014; 35(6):445-53. PubMed ID: 25433843 [TBL] [Abstract][Full Text] [Related]
10. The gastrointestinal microbiota in the development of ME/CFS: a critical view and potential perspectives. Stallmach A; Quickert S; Puta C; Reuken PA Front Immunol; 2024; 15():1352744. PubMed ID: 38605969 [TBL] [Abstract][Full Text] [Related]
11. A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis. Du Preez S; Corbitt M; Cabanas H; Eaton N; Staines D; Marshall-Gradisnik S Syst Rev; 2018 Dec; 7(1):241. PubMed ID: 30572962 [TBL] [Abstract][Full Text] [Related]
12. Numeric Rating Scales Show Prolonged Post-exertional Symptoms After Orthostatic Testing of Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. van Campen CLMC; Rowe PC; Verheugt FWA; Visser FC Front Med (Lausanne); 2020; 7():602894. PubMed ID: 33585505 [No Abstract] [Full Text] [Related]
13. Typing myalgic encephalomyelitis by infection at onset: A DecodeME study. Bretherick AD; McGrath SJ; Devereux-Cooke A; Leary S; Northwood E; Redshaw A; Stacey P; Tripp C; Wilson J; Chowdhury S; Lewis I; Almelid Ø; Baby SV; Baker T; Becher H; Boutin T; Clyde M; Garcia D; Ireland J; Kerr SM; McDowall E; Perry D; Samms GL; Vitart V; Wolfe JC; Ponting CP NIHR Open Res; 2023; 3():20. PubMed ID: 37881452 [TBL] [Abstract][Full Text] [Related]
14. Investigating Antibody Reactivity to the Intestinal Microbiome in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Feasibility Study. Seton KA; Defernez M; Telatin A; Tiwari SK; Savva GM; Hayhoe A; Noble A; de Carvalho-KoK ALS; James SA; Bansal A; Wileman T; Carding SR Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895005 [TBL] [Abstract][Full Text] [Related]
15. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians. Bested AC; Marshall LM Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325 [TBL] [Abstract][Full Text] [Related]
18. Problems in defining post-exertional malaise. Jason LA; Evans M; So S; Scott J; Brown A J Prev Interv Community; 2015; 43(1):20-31. PubMed ID: 25584525 [TBL] [Abstract][Full Text] [Related]
19. The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups. Twisk FN Front Physiol; 2014; 5():109. PubMed ID: 24734022 [TBL] [Abstract][Full Text] [Related]
20. Evaluating case diagnostic criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): toward an empirical case definition. Conroy KE; Islam MF; Jason LA Disabil Rehabil; 2023 Mar; 45(5):840-847. PubMed ID: 35236205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]